Effectiveness of different immunoadsorption columns for anti-A/B antibody depletion.

CONCLUSIONS: The semi-selective Therasorb Ig-omni5 device offers potential advantages in reducing total IgM as well as anti-A/B IgM antibodies.
PMID: 31447215 [PubMed - as supplied by publisher]

Source: Atherosclerosis Supplements - August 16, 2019 Category: Cardiology Authors: Speer C, Kälble F, Pego da Silva L, Nusshag C, Schaier M, Becker LE, Klein K, Beimler J, Sommerer C, Leo A, Süsal C, Mehrabi A, Zeier M, Morath C Tags: Atheroscler Suppl Source Type: research